Literature DB >> 20171777

Recurrent hydatidiform moles.

Denise Williams1, Victoria Hodgetts, Janesh Gupta.   

Abstract

Hydatidiform moles (HMs) are abnormal conceptions of excessive trophoblast development resulting in abnormal human pregnancies with no embryo and cystic degeneration of the chorionic villi. Prompt diagnosis, treatment and follow-up of patients using assays for betahCG from centres that specialise in this condition enable early diagnosis of potential malignant change. Hydatidiform moles occur quite frequently and although recurrence is rare, women who have experienced one molar pregnancy should be aware that they are at an increased risk of a further molar pregnancy in comparison to other women in the general population. For some women multiple molar pregnancies occur. In these women the recurrent molar pregnancies may be non-familial, referred to as recurrent molar hydatidiform moles in this article, or may result from an inherited predisposition, which we refer to as familial recurrent hydatidiform moles. We use the term familial biparental hydatidiform moles (FBHMs) for cases in which the parental contribution to the moles has been investigated and found to be biparental. It is important to recognise, however, that in some apparently non-familial cases, the absence of female siblings, or the absence of female siblings who have tried to conceive, may not allow the inherited nature of the molar pregnancies to manifest in more than one woman and be obviously familial. This review considers our current understanding about the aetiology of HMs and explores the mechanisms of both types of recurrent hydatidiform moles. It highlights the role that genetics can play in determining the origin of multiple molar pregnancies, which should be considered essential in providing women with accurate advice about their risk of recurrence, so allowing them to make appropriate reproductive choices. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20171777     DOI: 10.1016/j.ejogrb.2010.01.003

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  11 in total

1.  Pregnancy after oocyte donation in a patient with NLRP7 gene mutations and recurrent molar hydatidiform pregnancies.

Authors:  Claire Cozette; Florence Scheffler; Melyne Lombart; Jerome Massardier; Pierre-Adrien Bolze; Touria Hajri; Francois Golfier; Isabelle Touitou; Cecile Rittore; Jean Gondry; Philippe Merviel; Moncef Benkhalifa; Rosalie Cabry
Journal:  J Assist Reprod Genet       Date:  2020-06-26       Impact factor: 3.412

2.  Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis.

Authors:  Russell Vang; Mamta Gupta; Lee-Shu-Fune Wu; Anna V Yemelyanova; Robert J Kurman; Kathleen M Murphy; Cheryl Descipio; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

Review 3.  Recurrent complete hydatidiform mole: where we are, is there a safe gestational horizon? Opinion and mini-review.

Authors:  Ioannis Kalogiannidis; Kallirhoe Kalinderi; Michail Kalinderis; Dimosthenis Miliaras; Basil Tarlatzis; Apostolos Athanasiadis
Journal:  J Assist Reprod Genet       Date:  2018-05-08       Impact factor: 3.412

Review 4.  NLRP7 and related inflammasome activating pattern recognition receptors and their function in host defense and disease.

Authors:  Alexander D Radian; Lucia de Almeida; Andrea Dorfleutner; Christian Stehlik
Journal:  Microbes Infect       Date:  2013-04-22       Impact factor: 2.700

5.  Recurrent familial hydatidiform mole - a rare clinical problem.

Authors:  Lavanya Rai; Hebbar Shripad; Shyamala Guruvayare; Adiga Prashant; Anjali Sunil
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-12-01

Review 6.  Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine.

Authors:  Natalia Buza; Pei Hui
Journal:  Mod Pathol       Date:  2021-06-04       Impact factor: 7.842

Review 7.  NLRP7: From inflammasome regulation to human disease.

Authors:  Jessica Carriere; Andrea Dorfleutner; Christian Stehlik
Journal:  Immunology       Date:  2021-06-30       Impact factor: 7.215

8.  Association between gestational trophoblastic disease (GTD) history and clinical outcomes in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles.

Authors:  Xinyu Cai; Mei Zhang; Chenyang Huang; Yue Jiang; Jidong Zhou; Manlin Xu; Guijun Yan; Haixiang Sun; Na Kong
Journal:  Reprod Biol Endocrinol       Date:  2022-02-04       Impact factor: 5.211

9.  High-Risk Gestational Trophoblastic Neoplasia from a Homozygous NLRP7 Mutation.

Authors:  Zachary A Kopelman; Erica R Hope
Journal:  Gynecol Oncol Rep       Date:  2021-06-06

10.  Deep bisulfite sequencing of aberrantly methylated loci in a patient with multiple methylation defects.

Authors:  Jasmin Beygo; Ole Ammerpohl; Daniela Gritzan; Melanie Heitmann; Katrin Rademacher; Julia Richter; Almuth Caliebe; Reiner Siebert; Bernhard Horsthemke; Karin Buiting
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.